 |
|
|
| |
NGM282 Rapidly Improves NAFLD Activity Score (NAS) and Fibrosis in 12 Weeks in Patients with Biopsy-Confirmed Nonalcoholic Steatohepatitis(NASH)
Results of a Phase 2 Multi-Center Dose Finding Study
|
| |
| |
Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
Stephen A. Harrison, James F. Trotter, Angelo H. Paredes, Cynthia D. Guy, Mustafa R. Bashir, Mark J. Jaros, Rajarshi Banerjee, Bryan A. Baxter, Lei Ling, Stephen J. Rossi, Alex M. DePaoli
|
| |
|
|
|
|
|
